These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17168080)

  • 1. [Melatonin in the elderly and Alzheimer's disease].
    Savaskan E
    Praxis (Bern 1994); 2006 Nov; 95(47):1837-9. PubMed ID: 17168080
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of melatonin in Alzheimer's disease.
    Cardinali DP; Brusco LI; Liberczuk C; Furio AM
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():20-3. PubMed ID: 12019347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of melatonin in two individuals with Alzheimer's disease.
    Jean-Louis G; Zizi F; von Gizycki H; Taub H
    Percept Mot Skills; 1998 Aug; 87(1):331-9. PubMed ID: 9760668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human pineal gland and melatonin in aging and Alzheimer's disease.
    Wu YH; Swaab DF
    J Pineal Res; 2005 Apr; 38(3):145-52. PubMed ID: 15725334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin and Sleep Disturbances in Alzheimer's Disease.
    Prodhan AHMSU; Cavestro C; Kamal MA; Islam MA
    CNS Neurol Disord Drug Targets; 2021; 20(8):736-754. PubMed ID: 34348635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    López-Iglesias B; Pérez C; Morales-García JA; Alonso-Gil S; Pérez-Castillo A; Romero A; López MG; Villarroya M; Conde S; Rodríguez-Franco MI
    J Med Chem; 2014 May; 57(9):3773-85. PubMed ID: 24738476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Melatonin. Hormone or wonder drug?].
    Stoll S; Müller WE
    Med Monatsschr Pharm; 1996 Mar; 19(3):69-75. PubMed ID: 8868964
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in the treatment of Alzheimer's disease.
    Schneider LS
    Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceutical treatment of cognitive disorders in Alzheimer's disease.
    Senin U; Cherubini A; Palumbo B; Mecocci P
    Funct Neurol; 1997; 12(3-4):211-2. PubMed ID: 9218980
    [No Abstract]   [Full Text] [Related]  

  • 10. Is melatonin ready to be used in preterm infants as a neuroprotectant?
    Biran V; Phan Duy A; Decobert F; Bednarek N; Alberti C; Baud O
    Dev Med Child Neurol; 2014 Aug; 56(8):717-23. PubMed ID: 24575840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent.
    Cardinali DP; Furio AM; Reyes MP
    Ann N Y Acad Sci; 2005 Dec; 1057():327-36. PubMed ID: 16399904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin oxidative stress and neurodegenerative diseases.
    Srinivasan V
    Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective role of melatonin in oxidative stress vulnerable brain.
    Gupta YK; Gupta M; Kohli K
    Indian J Physiol Pharmacol; 2003 Oct; 47(4):373-86. PubMed ID: 15266948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Melatonina: old molecule, new medicament].
    Fernández-Tresguerres Hernández JA
    An R Acad Nac Med (Madr); 2008; 125(4):681-96. PubMed ID: 19496530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suprachiasmatic nucleus and melatonin: reciprocal interactions and clinical correlations.
    Benarroch EE
    Neurology; 2008 Aug; 71(8):594-8. PubMed ID: 18711114
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Alzheimer's disease.
    Mayeux R; Sano M
    N Engl J Med; 1999 Nov; 341(22):1670-9. PubMed ID: 10572156
    [No Abstract]   [Full Text] [Related]  

  • 17. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
    Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
    J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Melatonin as a drug: present status and perspectives].
    Arushanian ÉB
    Eksp Klin Farmakol; 2014; 77(6):39-44. PubMed ID: 25102735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Melatonin agonist: a possible disease-modifying agent for Alzheimer's disease].
    Matsubara E
    Nihon Rinsho; 2012 Feb; 70(2):349-52. PubMed ID: 22413544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin: new places in therapy.
    Maharaj DS; Glass BD; Daya S
    Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.